SEMrush
ascopubs.org

Please wait for loading...




    SEMrush

      (2677):

    /
     1  +2 2014 sep 27treatments on elderly non small cellNon – Small - Cell Lung Cancer in Elderly Patients: A Discussion of Non – Small - Cell Lung Cancer in Elderly Patients: A Discussion of ... on chemotherapy-related treatment decisions with some discussion of ...
     1  ~ 2014 sep 26breast cancer nomograms post mastectomyFull Text - Journal of Clinical Oncology - Ascopubs.orgThe role of postmastectomy radiotherapy (PMRT) has been ... between locoregional failures avoided and breast cancer deaths prevented is ... Those who subscribe to this point of view may indeed find this nomogram helpful.
     1  ~ 2014 sep 14j clin oncolJournal of Clinical OncologyIn print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but
     1  ~ 2014 sep 12journal of clinical oncologyJournal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print 
     1  ~ 2014 sep 09journal clinical oncology
     1  ~ 2014 sep 06afatinib lung 3Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients Purpose The LUX- Lung 3 study investigated the efficacy of chemotherapy compared with afatinib , a selective, orally bioavailable ErbB family ...
     1  ~ 2014 aug 29what is igfhttp://jco.ascopubs.org/cgi/glossarylookup?lookup=by_letter&letter=IigfWeb definitionsProteins with sequences similar to insulin, insulin-like growth factors trigger similar cellular responses as insulin, including mitogenesis. IGF-I (secreted by the liver) and IGF-II (secreted by brain, kidney, pancreas, and muscle) function through cell surface receptors. (See IGF-1R)http://jco.ascopubs.org/cgi/glossarylookup?lookup=by_letter&letter=I
     1  ~ 2014 aug 23dna methylation cancerDNA Methylation and Cancer - Journal of Clinical OncologyAbstract. DNA methylation is an important regulator of gene transcription, and its role in carcinogenesis has been a topic of considerable ...
     1  ~ 2014 aug 20what is rcbhttp://jco.ascopubs.org/cgi/glossarylookup?lookup=by_letter&letter=RrcbWeb definitionsAn index to estimate the extent of residual invasive cancer in the breast and regional lymph nodes after neoadjuvant chemotherapy. ...http://jco.ascopubs.org/cgi/glossarylookup?lookup=by_letter&letter=R
     1  ~ 2014 aug 13journal of oncologyJournal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print ... ‎JCO -- Archive of Issues by Date - ‎Information for Contributors - ‎Table of Contents
     1  +2 2014 aug 01soc advertising policiesAdvertising Policy of American Society of Clinical OncologyThese principles are applied by the American Society of Clinical ... matter of policy , ASCO will sell advertising space in its Publications. 1.
     1  ~ 2014 jul 29myelodysplastic syndrome life expectancyPrognostic Factors and Life Expectancy in Myelodysplastic Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision ...
     2  ~ 2014 sep 15prediction of anthracyclines induced cardiotoxicityPharmacogenomic prediction of anthracycline - induced cardiotoxicity Purpose Anthracycline - induced cardiotoxicity (ACT) is a serious adverse ... In the high-risk group, 75% of patients were accurately predicted to ...
     2  +2 2014 sep 09lux 5 lung cancer trialsLUX - Lung 4 - Journal of Clinical Oncology - Ascopubs.orgLUX -Lung 4: A Phase II Trial of Afatinib in Patients With. Advanced Non–Small- Cell Lung Cancer Who Progressed. During Prior .... nosed within the past 5 years , and brain tumors and/or brain metastases. (symptomatic or ...
     2  +2 2014 sep 01advanced renal cell carcinomaAbstract. PURPOSE: To identify prognostic factors and a model predictive for survival in patients with metastatic renal - cell carcinoma (RCC). PATIENTS AND ...
     2  +1 2014 aug 27pseudomyxoma peritonei prognosisPseudomyxoma Peritonei : More Questions Than AnswersPseudomyxoma Peritonei : More Questions Than Answers ... When patients were treated uniformly, the 5-year overall survival did not differ ...
     2  +10 2014 aug 23effectiveness chemotherapy lung cancerEffectiveness of Chemotherapy for Advanced Lung Cancer in the PURPOSE: To compare the effectiveness of chemotherapy given to elderly patients in routine practice for stage IV non–small-cell lung cancer  ...
     2  ~ 2014 aug 08intravesical gemcitabine bladder cancerIntravesical Gemcitabine Therapy for Superficial Transitional Cell Conclusion: Intravesical gemcitabine , at doses up to 2 g/wk, is well ... bladder cancer .19 In addition, gemcitabine possesses pharmaco- kinetic properties that ...
     3  +20 2014 sep 27most expensive cancer drugs 2011Can Patients Afford to Be Adherent to Expensive Oral Cancer Drugs The increased availability of oral cancer agents in oncology care is promoting a
     3  ~ 2014 sep 23stager integrated systemsImproved Prognostication of Renal Cell Carcinoma Using an Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System . By Amnon Zisman, Allan J. Pantuck, Fredrick Dorey, Jonathan W. Said, ...
     3  +1 2014 sep 17healthbridge cincinnatiCincinnati's HealthBridge : Bringing Results From Multiple Service Robert C. Steffel is the CEO of HealthBridge in Cincinnati , Ohio. ... clearing- house known as HealthBridge , the 2.2 million people living in greater Cincinnati ,  ...
     3  ~ 2014 sep 15d1 vs d2 resectionLymphadenectomy for Gastric Cancer - Journal of Clinical OncologyA D1 lymphadenectomy includes only those nodes adjacent to the ... randomized trial of D1 dissection compared to D2 dissection .2,3 The ...
     3  ~ 2014 sep 14j 30 définitionDefinition and Impact of Pathologic Complete Response - Journal of The exact definition of pathologic complete response (pCR) and its prognostic impact on survival ... J Clin Oncol 30 :1796-1804. © 2012 by ...
     3  ~ 2014 sep 07oncology mediaJournal of Clinical Oncology - Information for AdvertisersAccording to Kantar Media's Perq/HCI focus study from June 2012, the Journal of Clinical Oncology (JCO) provides advertisers with more readers and more ...
     3  -1 2014 aug 22double hit lymphoma treatmentDouble - Hit Diffuse Large B-Cell Lymphoma... the outcome of these patients treated with six cycles of R-CHOP was excellent, ... This combination of genetic abnormalities is also called double - hit .... This combination of abnormalities represents double - hit lymphoma .
     3  -2 2014 aug 18whole brain radiationOn the Merits and Limitations of Whole - Brain Radiation TherapyThis is the first such analysis in a randomized trial of observation or whole - brain radiation therapy ( WBRT ) after focal therapy (surgery or ...
     3  -1 2014 aug 16testicular cancer and bleomycinBleomycin in Testicular Cancer : Will Pharmacogenomics Improve Bleomycin is an antibiotic with anticancer properties produced by Streptomyces verticillus. It was identified in 1966, and one of its mechanisms ...
     3  -2 2014 aug 12upper tract bladder cancerUpper - Tract Tumors After an Initial Diagnosis of Bladder Cancer per- tract tumors (UTT) after bladder cancer , stratified by bladder tumor ... lance of bladder cancer patients with upper - tract imaging. The temporal pattern of ...
     3  +1 2014 aug 03tyrosine kinase inhibitor thyroidHow to Incorporate New Tyrosine Kinase Inhibitors in the Treatment Medullary thyroid cancer (MTC), a neuroendocrine tumor arising from the parafollicular C cells of the thyroid gland, is rare and accounts for ...
     4  ~ 2014 sep 23antonin levy medical oncologyComputed Tomography–Based Simulation for Thoracic Radiation Corresponding author: Antonin Levy , MD, Radiation Oncology , Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France; ...
     4  -3 2014 sep 21cam breasyUse of Complementary/Alternative Medicine by Breast Cancer Abstract. PURPOSE: To determine the prevalence of use of complementary/ alternative medicine ( CAM ) by breast cancer survivors in Ontario, Canada, and to  ...
     4  +1 2014 sep 12the trial epicEPIC : Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer.
     4  -2 2014 sep 01american society of clinical oncologyAmerican Society of Clinical Oncology - Journal of Clinical OncologyASCO makes no representation that the Website or the services available through the Website are appropriate or available for use in all ...
     4  +7 2014 aug 31anecdotes and case reportsEssence of Evidence-Based Medicine: A Case Report - Journal of approach relegates the case report to a category of lowest quality of evidence to ... However, case reports represent stories , or anecdotes , that can be framed in.
     4  +4 2014 aug 23physician malpractice insuranceMalpractice Insurance : What You Need to KnowIf you are just starting practice as an employee with a physician group, you may think you don't really need to know that much about malpractice insurance .
     4  -2 2014 aug 13clinical cancer advances reportClinical Cancer Advances 2013: Annual Report on Progress Against Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. Jyoti D. Patel ...
     4  +4 2014 aug 11platinum with antifolatePhase I study of MORAb-003, a humanized anti-folate receptor Phase I study of MORAb-003, a humanized anti-folate receptor-alpha monoclonal antibody, in platinum resistant ovarian cancer. J. A. Konner, S. Ahmed, ...
     4  +5 2014 aug 10zol cancer drugSynergistic effect of ibandronate (Ib) and zoledronic acid ( Zol ) in Synergistic effect of ibandronate (Ib) and zoledronic acid ( Zol ) in different drug regimens in breast tumor growth inhibition (BTGI) in ATP-cell viability assay (ATP - ...
     4  ~ 2014 aug 01lymph node involvementSignificance of Axillary Lymph Node Metastasis in Primary Breast The following explanatory variables and their first-order interactions were considered: number of axillary lymph nodes involved (zero v one to three v four or ...
     4  +4 2014 jul 16egfr testing insuranceASCO Provisional Clinical Opinion: Epidermal Growth Factor In the community setting, testing to determine patients' EGFR mutation status .... to advocate for their patients with insurance companies on this matter, as EGFR  ...
     5  +2 2014 sep 29discussion of interstitial pneumonia induced by liposomalPulmonary Fibrosis After Pegylated Liposomal Doxorubicin in a Pegylated liposomal doxorubicin is a liposome -encapsulated form of doxorubi- cin. .... drome), and pleural effusions.9 Interstitial pneumonitis caused by ... In conclusion , the prognosis for patients with recurrent UPSC is poor.
     5  -1 2014 sep 27payer provider in oncologyOncology Management Programs for Payers and Physicians After 4 to 5 years of experience with some of these external oncology management models, both payers and providers are learning about the impact they have ...
     5  +38 2014 sep 18pascale landauSymptomatic Treatment With Lanreotide Microparticles in Inoperable Corresponding author: Pascale Mariani, MD, Department of Surgery, Institut Curie, 26 rue d'Ulm 75248, Paris Cedex 05, France; e-mail: ...
     5  +13 2014 sep 02chia v rennieDouble-Blind, Randomized Placebo Controlled Trial of Fulvestrant Corresponding author: Stephen Chia , MD, Division of Medical Oncology, British
     5  +96 2014 aug 30tactics of negotiationPrinciples and Tactics of Negotiation - Journal of Oncology PracticePrinciples and Tactics of Negotiation . Do you want more vacation time? A better managed care agreement? A seat on an influential committee? A bank loan?
     5  +5 2014 aug 21clinical trial costThe Costs of Conducting Clinical Research - Journal of Clinical hours and costs associated with conducting a mock phase III clinical research ... enrolling subjects in clinical research trials .4 Furthermore, critics contend that ...
     5  +3 2014 aug 19follicular lymphoma survival rateCurability of Advanced Indolent or Low-Grade Follicular Lymphomas With the advent of rituximab, their average survival has been ... goals of phase II trials can then become response rate and progression-free survival ; ... Wilms tumor is not necessarily correct for low-grade follicular lymphoma .
     5  +2 2014 aug 15communication skills developmentDeveloping Effective Communication Skills - Journal of Oncology Developing Effective Communication Skills . A practicing oncologist likely uses just about every medium to communicate. They talk on the phone, send e-mail ...
     5  +9 2014 aug 14effective communication skillsDeveloping Effective Communication Skills
     5  +3 2014 aug 13vitamin d deficiency treatmentHow I Treat Vitamin D Deficiency - Journal of Oncology PracticeChronic vitamin D deficiency in adults results in osteoporosis, osteomalacia, .... The first step in treating vitamin D deficiency is to obtain a baseline 25(OH)D ...
     5  ~ 2014 aug 03jil sande mantel papierRadiation Dose and Breast Cancer Risk in the Childhood Cancer ... to unblocked from a mantle field), the breast dose was set to unknown. ..... Committee); Children's Hospital of Philadelphia, PA: Jill Ginsberg, MD ... MD, MSPH (Institutional Principal Investigator), Jane Sande , MD (Former ...
     5  +3 2014 jul 25granular cell tumorGranular Cell Tumor of the Breast: Clinical and Pathologic Introduction. Granular cell tumor (GCT) of the breast is a rare neoplasm that accounts for 5% to 6% of all GCTs and is usually benign in nature.
     5  +4 2014 jul 21oncologia carrara tagliagambaPrimary Tumor Response to Preoperative Chemoradiation With or ... Angiolo Tagliagambe , Azienda Sanitaria Locale 1, Massa Carrara ; ... Corresponding author: Carlo Aschele, MD, PhD, Oncologia Medica ...
     6  +95 2014 sep 18modg proclamation of richesAn Embarrassment of Riches : Neoadjuvant Therapy of Rectal CancerAn Embarrassment of Riches : Neoadjuvant. Therapy of Rectal Cancer
     6  +8 2014 sep 11progressive registry analysisRegistries That Show Efficacy: Good, but Not Good EnoughTo minimize these threats to validity, analyses of registry data should .... inhibition with bevacizumab beyond progressive disease could play an ...
     6  +3 2014 sep 09palliative care quality of lifePalliative Care and the Quality of Life - Journal of Clinical OncologyResearch demonstrates that palliative care improves symptom distress, quality of life , patient and family well-being, and in some settings (eg, ...
     6  +14 2014 sep 08oligode glioomPhase II Trial of Temozolomide in Patients With Progressive Low Results: Forty-six patients with low-grade glioma have been treated to date. ..... glioma have included, almost exclusively, grade 2 astrocytomas, oligoden -.
     6  +5 2014 sep 01daily study schedule clsPhase I and Pharmacokinetic Study of Temozolomide on a Daily -for ( ClS /F) averaging 1.8 hours and 115 mL/min/m2, respec- tively. .... phase I study of TMZ on this schedule .6 The dose of TMZ was increased in successive groups  ...
     6  +16 2014 aug 31icrf cancer curesICRF -187 Permits Longer Treatment With Doxorubicin in Women Twenty-six patients in the ICRF -187 group received doxo- rubicin doses of at least 700 ... adjuvant therapy in breast cancer , may also not be treated. We have  ...
     6  +5 2014 aug 22malpractice insurance for doctors“The group pays for malpractice insurance , and tail coverage is often not spelled out if the physician leaves. After 2 or 3 years, the doctor wants to leave the ...
     6  +95 2014 aug 06isalc lung cancerNew Pathologic Classification of Lung Cancer : Relevance for ... the Study of Lung Cancer /American Thoracic Society/European Respiratory Society ( IASLC /ATS/ERS) lung adenocarcinoma classification.
     6  +2 2014 aug 01salz alfa pharmaceuticalsCancer Drugs in the United States: Justum Pretium—The Just PricePharmaceutical companies justify the high price of drugs as necessary to support investment in research and development. ... (2007), everolimus (2009), bevacizumab (with interferon alfa ; 2009), ..... Bach P,; Salz L,; Wittes R.
     6  +1 2014 jul 31cost savings of transplantOutpatient-Based Bone Marrow Transplantation for Hematologic CONCLUSION: Increased use of outpatient-based BMT should produce substantial cost savings for payers without adverse effects on patients for those patients ...
     6  ~ 2014 jul 31thymoma survival rateTumor Recurrence and Survival in Patients Treated for Thymomas Among 75 patients with B2 and B3 thymomas with incomplete resection or a tumor stage III or higher, the recurrence rate was 34% (n = 23) ...
     6  +5 2014 jul 31cancer chemo sensitivityUse of Chemotherapy Sensitivity and Resistance Assays (CSRAs) for ... recurrent ovarian cancer to assay-directed chemotherapy (n = 94) or ...
     6  -3 2014 jul 27strategic planning in healthcareStrategic Planning : Why It Makes a Difference, and How to Do ItIn the field of health care today, a long-term plan will likely address no more than the next 3 years. After the strategic course is determined in the initial planning  ...
     6  -5 2014 jul 25google prostate foodUS Food and Drug Administration Approval of Drugs for the Institution: Google Indexer ... drugs were approved by the US Food and Drug Administration (FDA) for the treatment of prostate cancer (PC),1–3 ...
     7  +19 2014 sep 10human monoclonal antibodies cancerMonoclonal Antibodies in Cancer Therapy: 25 Years of ProgressWhereas passive serotherapy of human cancer had shown little success,3 it was apparent in the earlier review that monoclonal antibodies  ...
     7  +50 2014 sep 09effective communicationBe an Active Listener. The starting place for effective communication is effective listening. “Active listening is listening with all of one's senses,” says physician ...
     7  -1 2014 sep 07siopel 3Successful Treatment of Childhood High-Risk Hepatoblastoma With Survival Results of the SIOPEL -3HR Study Compared With the Results of Recent ... SIOPEL -3HR, M+, 70, 4.5, 3 , 56, 44 to 68, 3 , 62, 50 to 73.
     7  ~ 2014 aug 24metastatic colorectal cancerTreatment of Metastatic Colon Cancer - Journal of Clinical OncologyIn the 1950s, colon cancer was the poor stepchild for chemotherapists, with a median survival of 12 months for patients with metastatic disease.
     7  +6 2014 aug 21therapy first in alFirst , the overall treatment duration of bevacizumab and placebo .... C et al : XELOX (capecitabine plus oxaliplatin): Active first -line therapy for ...
     7  +5 2014 aug 21develop communication skills
     7  +4 2014 aug 08invasive ductal carcinoma radiotherapySelecting Individualized Treatment for Patients With Ductal DCIS can be a precursor for development of a subsequent invasive breast carcinoma in some patients. The goal of adding radiation treatment  ...
     7  -2 2014 aug 08chemo regimen for ilcInvasive Lobular Carcinoma Classic Type: Response to Primary Patients with ILC tended to be older (median age, 53 years v 47 years for ... chemotherapy is the standard treatment for patients presenting with ...
     7  +2 2014 aug 07monica genesys meeting centerComparative analysis of bone marrow (BM) micrometastasis (M Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings ... Center , Santa Monica , CA; Genesys Regional Medical Center , Grand Blanc, MI. 508.
     7  -1 2014 aug 06cervical cancer hydrogelNovel Use of a Hydrogel Spacer Permits Reirradiation in Otherwise Uterine cancer comprises 47,000 cases and cervical cancer approximately 12,000.1 Up to 40% of patients with these cancers (specifically ...
     7  +6 2014 aug 06cohen anticancer jean michelTable of Contents — March 20, 2013, 31 (9)Identification of a 24-Gene Prognostic Signature That Improves the .... Ligases and the Proteasome in Oncogenesis: Novel Targets for Anticancer Therapies .... Régis Cohen ,; Jean - Michel Coindre,; and Jean-Jacques Mourad.
     7  +1 2014 aug 05xtc social bookmarksA randomized phase II study of Xcellerated T Cells with or without In the current study, pts with relapsed/refractory MM were randomized to XTC ± 1 ... All pts received a single dose of 60–100 x 109 XTC . ... Social Bookmarking .
     7  +1 2014 aug 05the communication is promptUsing a Question Prompt List As a Communication Aid in Advanced Purpose: Oncologists and patients often avoid discussing prognosis, treatment failure, and end-of-life planning. Thus, many patients still overestimate their ...
     7  ~ 2014 aug 03wheatgrass juice for cancerEffect of wheat grass juice in supportive care of terminally ill cancer Netaji Subhash Chandra Bose Cancer Research Institute, Kolkata, India. 8634. Background: The solid content of juice made from wheat grass is 70% ...
     7  +94 2014 jul 29malignant melanoma and cllOther Malignancies in Chronic Lymphocytic Leukemia /Small Criteria used for the diagnosis of CLL /SLL and other malignancies are .... other myeloid (including monocytic) leukemias, melanoma , and ...
     7  +21 2014 jul 26inhibiting dht and estrogenA new mechanism of estrogen action in prostate cancer: Inhibition of The mechanisms whereby estrogens inhibit 'androgen-independent' prostate ... ( T) and dihydrotestosterone ( DHT ) levels were evaluated by radioimmunoassay.
     7  -1 2014 jul 23berry brian giacconeAcknowledgment of Authors - Journal of Oncology PracticeBerry , Carolyn. Berry , Donna. Berry , Scott. Bible, Keith ... Chen, Brian . Chen, Ling . Chesnick, Megan ... Giaccone , Giuseppe. Gillman, Matt. Gilmore, James.
     8  +19 2014 oct 03chen the metaMeta -Analysis of BRCA1 and BRCA2 PenetranceAddress reprint requests to Sining Chen , PhD, Johns Hopkins ... of the at-risk population, we address this issue through a meta -analysis.
     8  -3 2014 oct 02methylation of dna
     8  ~ 2014 sep 29oncology competitor analysis worksheetFinancial Management in Oncology Practice, Part 2: Billing and But even though coding and billing are routine parts of oncology practice, they
     8  -1 2014 sep 21medical imaging errorsPhysical Examination, Diagnostic Imaging , and Medical ErrorsMy recent 2-week stint on the inpatient hematology teaching service led me to reflect on the importance of the physical examination. Most of us spent a lot of time ...
     8  +44 2014 sep 12source trial of sorafenibRandomized, Double-Blind, Placebo-Controlled, Phase II Trial of Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced ...
     8  +1 2014 sep 10renal cell carcinoma prognosisSurvival and Prognostic Stratification of 670 Patients With Advanced
     8  -1 2014 sep 05folfirinoxFOLFIRINOX : A Small Step or a Great Leap Forward?There was a statistically significant improvement for the FOLFIRINOX arm in terms of the primary end point, overall survival (median of 11.1 v ...
     8  +4 2014 aug 29disease free survivalDisease - Free Survival Versus Overall Survival As a Primary End In this issue of the Journal of Clinical Oncology, Sargent et al1 evaluated disease - free survival with 3 years of follow-up (DFS3 years) as a ...
     8  -6 2014 aug 29cancer bilateral sanAbstract - Journal of Clinical Oncology - Ascopubs.orgPresented at the 33rd San Antonio Breast Cancer Symposium, ... about whether patients with synchronous bilateral breast cancer (SBBC) have ...
     8  +13 2014 aug 26down syndrome leukemiaDown Syndrome and Acute Myeloid Leukemia : The Paradox of Down Syndrome and Acute Myeloid Leukemia : The Paradox of Increased Risk for Leukemia and Heightened Sensitivity to Chemotherapy.
     8  +4 2014 aug 17rate in retePrognostic Factors for Relapse in Stage I Seminoma Managed by actuarial 5-year relapse-free rate (RFR) of 82.3%. On uni- variate analysis, tumor size (RFR: < 4 cm, 87%; > 4 cm, 76%;. P .003), rete testis invasion (RFR: 86% ...
     8  +4 2014 aug 16anthony robbins data baseAbstract - Journal of Clinical OncologyCorresponding author: Anthony S. Robbins , MD, PhD, Health ... to 2005 data from the National Cancer Data Base , a national hospital-based ...
     8  -2 2014 aug 08metastatic colon cancer
    1 2 of 27 pages    




    SEMrush